What Are Wall Street Analysts' Target Price for Viatris Stock?

With a market cap of $15.1 billion, Viatris Inc. (VTRS) is a global healthcare company operating across North America, Europe, Asia-Pacific, Africa, Latin America, and the Middle East, delivering a broad portfolio of branded, generic, complex, and biosimilar medicines. Through its four regional segments, the company serves multiple therapeutic areas and distributes its products worldwide via diverse pharmacy and healthcare channels.

Shares of the Canonsburg, Pennsylvania-based company have slightly outperformed the broader market over the past 52 weeks. VTRS stock has soared 14.6% over this time frame, while the broader S&P 500 Index ($SPX) has gained 14.3%. Moreover, the stock has returned 5.1% on a YTD basis, compared to SPX's 1.4% rise.